Literature DB >> 15150351

Methylglyoxal: a stimulus to neutrophil oxygen radical production in chronic renal failure?

Richard A Ward1, Kenneth R McLeish.   

Abstract

BACKGROUND: Chronic renal failure is characterized by oxidant stress, resulting in part from increased reactive oxygen species production by neutrophils. Plasma concentrations of methylglyoxal are increased in uraemia. Methylglyoxal activates p38 mitogen-activated protein kinase (MAPK) in endothelial cells. Activation of p38 MAPK in neutrophils enhances reactive oxygen species production through exocytosis of intracellular storage granules. We tested the hypothesis that methylglyoxal enhances reactive oxygen species production by activating p38 MAPK in neutrophils.
METHODS: Neutrophils were exposed to methylglyoxal in vitro. Activation of p38 MAPK was determined by immunoblot analysis. Exocytosis was determined by measuring plasma membrane expression of CD35 and CD66b, specific markers of secretory vesicles and specific granules, respectively. Reactive oxygen species production was determined by measuring H(2)O(2) and O(-)(2) production.
RESULTS: Methylglyoxal activated p38 MAPK and caused dose-dependent increases in CD35 and CD66b expression, which were blocked by the methylglyoxal scavenger, aminoguanidine, or the p38 MAPK inhibitor, SB203580. Methylglyoxal caused dose-dependent increases in basal and Staphylococcus aureus-stimulated H(2)O(2) production and basal and formyl-methionyl-leucyl-phenylalanine-stimulated O(-)(2) production. Enhancement of reactive oxygen species production was blocked by aminoguanidine and SB203580.
CONCLUSIONS: Methylglyoxal enhances reactive oxygen species production in neutrophils through a process involving p38 MAPK-dependent exocytosis of intracellular storage granules. These findings, together with the observation that methylglyoxal concentrations are increased in renal failure, suggest a possible role for methylglyoxal as a uraemic toxin that contributes to the oxidant stress associated with renal failure.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15150351     DOI: 10.1093/ndt/gfh271

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  7 in total

1.  Effect of methylglyoxal modification of human α-crystallin on the structure, stability and chaperone function.

Authors:  S Mukhopadhyay; M Kar; K P Das
Journal:  Protein J       Date:  2010-11       Impact factor: 2.371

2.  Methylglyoxal scavengers attenuate endothelial dysfunction induced by methylglyoxal and high concentrations of glucose.

Authors:  Arti Dhar; Indu Dhar; Kaushik M Desai; Lingyun Wu
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

3.  Counterregulation of clathrin-mediated endocytosis by the actin and microtubular cytoskeleton in human neutrophils.

Authors:  Silvia M Uriarte; Neelakshi R Jog; Gregory C Luerman; Samrath Bhimani; Richard A Ward; Kenneth R McLeish
Journal:  Am J Physiol Cell Physiol       Date:  2009-01-28       Impact factor: 4.249

Review 4.  Methylglyoxal, obesity, and diabetes.

Authors:  Paulo Matafome; Cristina Sena; Raquel Seiça
Journal:  Endocrine       Date:  2012-09-16       Impact factor: 3.633

Review 5.  Immune Dysfunction in Uremia 2020.

Authors:  Gerald Cohen
Journal:  Toxins (Basel)       Date:  2020-07-05       Impact factor: 4.546

Review 6.  Immune dysfunction in uremia—an update.

Authors:  Gerald Cohen; Walter H Hörl
Journal:  Toxins (Basel)       Date:  2012-10-24       Impact factor: 4.546

Review 7.  Role of methylglyoxal in Alzheimer's disease.

Authors:  Cristina Angeloni; Laura Zambonin; Silvana Hrelia
Journal:  Biomed Res Int       Date:  2014-03-09       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.